New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
DXSE

Xtrackers MSCI Europe Health Care UCITS ETF

Passive ETFEquity
Not rated

The DXSE Exchange Traded Fund (ETF) is provided by Xtrackers by DWS. It is built to track an index: MSCI Europe Health Care 20/35 Capped Index. The DXSE ETF provides physical exposure, so by buying it you actually own parts of all the 38 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

€242.40
+€4.9 (+2.08%) yesterday
7:00 AM 10/22/26 Closed
1D price range
€237.00€242.40
52W price range
€207.70€242.50
YTD Perf.
+5.23%
YTD Flows
Annualized volatility
Fund AuM
€332M
Share class AuM
€332M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
LU0292103222
TER
0.17%
Inception date
6/26/2007
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Oct 21, 2026
-6%-4%-2%0%2%4%6%8%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 08/31/26
Healthcare
94.98%
Consumer Cyclicals
3.05%
Unavailable
1.22%
Other
0.75%
Latest DXSE news

FAQ about DXSE

DXSE is a Passive ETF. This ETF provides exposure to Large and Mid-Cap European Health Care Equities.
DXSE tracks the MSCI Europe Health Care 20/35 Capped GTR Index - EUR, through a full replication replication method.
DXSE carries a total expense ratio (TER) of 0.17%, indicating the annual cost for holding the fund.
DXSE was introduced to the market on June 26, 2007. It trades on United Kingdom, among other exchanges
Xtrackers MSCI Europe Health Care UCITS ETF, DXSE, is provided by Xtrackers by DWS. Learn more about Xtrackers by DWS here.
DXSE oversees €332M in assets as of October 21, 2026.
DXSE follows a capitalizing, meaning it reinvests income within the fund.
As of August 31, 2026, DXSE has significant geographic allocations in Switzerland, United Kingdom and Denmark.
As of August 31, 2026, DXSE focuses largely on Healthcare and Consumer Cyclicals.
As of August 31, 2026, DXSE holds 38 positions in its portfolio, with 86.38% of assets concentrated in its top 15 holdings.
As of August 31, 2026, DXSE top three holdings include Roche Holding AG, Novartis AG and AstraZeneca PLC.
The base currency of DXSE is EUR.
Data as of 08/31/26
Roche Holding AG
16.86%
Novartis AG
15.16%
AstraZeneca PLC
13.30%
Novo Nordisk A/S
7.99%
GSK Plc
5.51%
Sanofi
5.29%
argenx SE
3.48%
EssilorLuxottica SA
3.05%
Bayer AG
3.00%
Lonza Group AG
2.74%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight